In fact, people living with type 2 diabetes are more likely to develop and die from cardiovascular diseases, such as heart attacks, stroke, and heart failure than people who don't have diabetes
Could the combination produce unexpected effects that neither medication causes alone
The chart below shows the Retatrutide weight loss results based on the dose and duration: The Retatrutide clinical trials are still underway with a planned Phase IV beyond the current Phase III
Genetic rescue of nonclassical ER signaling normalizes energy balance in obese Er-null mutant mice
The Complete Nutritional Support System
Id love to see a dosing trial of patients like this, perhaps looking at smaller initiation doses, or spreading the doses out differently, either by less frequent dosing, or more frequent but lower doses that still get to the same eventual pharmacologic levels